# Guoke Venture

> Guoke Venture is a VC fund in Suzhou backing Medical, Health Care and Biotechnology. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Suzhou, China
- Total investments: 16
- Last investment: Mar 2026
- Lead investor: 31%
- Last updated: Aug 2026

Guoke Venture is a VC fund in Suzhou focused on Medical and Health Care. Guoke Venture provides investment consulting, investment management, and asset management services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 19% |
| Health Care | 3 | 19% |
| Biotechnology | 3 | 19% |
| Manufacturing | 3 | 19% |
| Hardware | 2 | 13% |

27 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 25% |
| Series A | 4 | 25% |
| Series B | 2 | 13% |
| Series E | 2 | 13% |
| Angel | 1 | 6% |

8 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ruoyi Biotech | Ruoyi Biotech is a developer of macromolecular drug delivery technology. |  | Series A | Mar 16, 2026 |  |
| Hefei Jiayu Technology | Hefei Jiayu Technology is a developer of magnetic particle imaging equipment. | $1.4M | Angel | Nov 12, 2025 |  |
| Jiayu Medical | Jiayu Medical is a leading domestic developer of MPI (Magnetic Particle Imaging) technology. |  | Seed | Nov 11, 2025 |  |
| Xingmu | Xingmu creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses. |  | Series A | Sep 12, 2025 |  |
| Suzhou Ribo Life Science | Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients. | $27.9M | Series E | Jul 21, 2025 |  |
| TwinSolution | TwinSolution is a professional test interface product and solution provider in the semiconductor sector. |  | Series C | Mar 26, 2025 |  |
| ICT Developer | ICT Developer is a domestic green and sustainable fuel company. |  | Series A | Dec 30, 2024 |  |
| Yidon Technologies | Yidong Optic is a company that developers high-resolution field emission scanning electron microscopes. Yidong Optics' core products are high-resolution field emission scanning electron microscope projects, with a focus on research and development, manufacture, and application of charged particle microscopes. |  | Seed | May 20, 2024 |  |
| Zhongke Ruili | Zhongke Ruili is a functional materials developer, focused on the design, research and development, manufacture, sales, and application of functional materials. Zhongke Ruili provide liquid separation, gas-liquid separation, and specific functional material separation methods. | $1.4M | Seed | May 07, 2024 |  |
| Zhongnong Provenance | Zhongnong Provenance is an agricultural animal design and breeding service provider. |  | Seed | Feb 09, 2023 |  |

10 of 16 investments shown.

## Co-investors
- [Kunshan Hi-tech Venture Capital](https://shizune.co/investors/profile/kunshan-hi-tech-venture-capital) — VC Fund, 3 deals together
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- Anhui Railway Development Fund — VC Fund, 1 deal together
- [BAIC Capital](https://shizune.co/investors/profile/baic-capital) — VC Fund, 1 deal together
- [CAS Investment Management](https://shizune.co/investors/profile/cas-investment-management) — VC Fund, 1 deal together
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Guoke Venture invest in?

Guoke Venture invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Guoke Venture last invest?

The most recent investment recorded for Guoke Venture closed in Mar 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co